MaxCyte Inc Sustainability Reports
MaxCyte, Inc. provides cell-engineering platform technologies based on proprietary electroporation to advance the discovery, development, and commercialization of next-generation cell therapeutics.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 54930053YHXULRFCU991
FIGI: BBG00CFTQNG7
11 reports from 2016 to 2025
